...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Bear
2
Apr 16, 2018 08:56AM
2
Apr 16, 2018 01:24PM

Apr 16, 2018 04:24PM
4
Apr 16, 2018 08:07PM
2
Apr 17, 2018 02:08AM

My comment had nothing to do with the trial and why once again there is a failure around delivery on management set expectations. My comment was only on the failure to update the clinicaltrials.gov website. I’m pretty sure the trial is no longer anticipated to start this past Mar 15. 

1
Apr 17, 2018 03:32PM

Apr 17, 2018 05:13PM
Share
New Message
Please login to post a reply